HAD: An automated database tool for analyzing screening hits in drug discovery

被引:13
作者
Shen, J [1 ]
机构
[1] Aventis Pharmaceut Inc, Bridgewater, NJ 08807 USA
来源
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES | 2003年 / 43卷 / 05期
关键词
D O I
10.1021/ci034067s
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Collecting, organizing, and reviewing chemical information associated with screening hits are human time-consuming. The task depends highly on the individual, and human errors may result in missing leads or wasting resources. To overcome these hurdles, we have developed a decision support system, Hits Analysis Database (HAD). HAD is a software tool that automatically generates an ISIS database file containing compound structures, biological activities, calculated properties such as clogP, hazard fragment labels, structure classifications, etc. All data are processed by available software and packed into a single SD file. In addition to search capabilities, HAD provides an overview of structural classes and associated activity statistics. Chemical structures can be organized by maximum common substructure clustering. The ease of use and customized features make HAD a chief tool in lead selection processes.
引用
收藏
页码:1668 / 1672
页数:5
相关论文
共 11 条
[1]   Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration [J].
Clark, DE .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (08) :815-821
[2]  
COELS S, 2002, 224 ACS NAT M
[3]  
CROWN RD, 1998, 216 ACS NAT M
[4]  
Demesmaeker M, 2001, RATIONAL APPROACHES TO DRUG DESIGN, P506
[5]  
LEACH AR, 2001, 221 ACS NAT M
[6]   Drug-like properties and the causes of poor solubility and poor permeability [J].
Lipinski, CA .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2000, 44 (01) :235-249
[7]   Problem solving as model refinement: Towards a constructivist epistemology [J].
Luger, GF ;
Lewis, J ;
Stern, C .
BRAIN BEHAVIOR AND EVOLUTION, 2002, 59 (1-2) :87-100
[8]  
MARCHANT CA, 1996, BIOACTIVE COMPOUND D, P153
[9]  
Shen J, 2002, ABSTR PAP AM CHEM S, V223, pU498
[10]  
SHEN J, 2001, 221 ACS NAT M